Related Experiment Video
Updated: Jul 1, 2025

Murine Model of CD40-activation of B cells
Published on: March 5, 2010
CD40 Expression by B Cells Is Required for Optimal Immunity to Murine Pneumocystis Infection
Monica Sassi1, Shelly J Curran1, Lisa R Bishop1
1Critical Care Medicine Department, NIH Clinical Center, National Institutes of Health, Bethesda, Maryland.
Abstract:
CD40-CD40 ligand interactions are critical for controlling Pneumocystis infection. However, which CD40-expressing cell populations are important for this interaction have not been well defined. We used a cohousing mouse model of Pneumocystis infection, combined with flow cytometry and quantitative polymerase chain reaction, to examine the ability of different populations of cells from C57BL/6 mice to reconstitute immunity in CD40 knockout mice. Unfractionated splenocytes, as well as purified B cells, were able to control Pneumocystis infection, while B cell-depleted splenocytes and unstimulated bone marrow-derived dendritic cells were unable to control infection in CD40 knockout mice. Pneumocystis antigen-pulsed bone marrow-derived dendritic cells showed early but limited control of infection. Additional findings were consistent with recent studies that suggested a role for antigen presentation by B cells; specifically, by using cells from immunized animals, B cells were able to present Pneumocystis antigens to induce proliferation of T cells. Thus, CD40 expression by B cells appears necessary for robust immunity to Pneumocystis.

